Canada markets closed

KetamineOne Capital Limited (MEDI.NE)

NEO - NEO Real Time Price. Currency in CAD
Add to watchlist
0.5000+0.0350 (+7.53%)
At close: 3:27PM EDT

KetamineOne Capital Limited

1917 West 4th Avenue
Suite 340
Vancouver, BC V6J 1M7
Canada

http://www.ketamine.one

Sector(s)Healthcare
IndustryMedical Care Facilities
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter Nguyen C.A., C.P.A.CFO & Director14.6kN/A1987
Mr. Adam Deffett C.F.A.Interim CEO, VP of Capital Markets & CommunicationsN/AN/AN/A
Dr. Mark KimminsChief Medical Officer & Chairman of Medical Advisory BoardN/AN/AN/A
Ms. Najla GuthrieChief Research OfficerN/AN/AN/A
Mr. Keith WhitePres of Clinic OperationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as Myconic Capital Corp. and changed its name to KetamineOne Capital Limited in June 2021. KetamineOne Capital Limited was founded in 2017 and is headquartered in Vancouver, Canada.

Corporate Governance

KetamineOne Capital Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.